Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Gilead Sciences Market Cap 2006-2019 | GILD

Gilead Sciences market cap history and chart from 2006 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Gilead Sciences market cap as of March 27, 2020 is $92.99B.
  
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $92.991B $22.449B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. Their portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $117.071B 13.38
CSL (CSLLY) Australia $85.089B 0.00
Vertex Pharmaceuticals (VRTX) United States $58.203B 52.82
Biogen (BIIB) United States $53.079B 9.06
Regeneron Pharmaceuticals (REGN) United States $49.761B 21.08
Illumina (ILMN) United States $40.340B 41.71
Seattle Genetics (SGEN) United States $20.006B 0.00
Alexion Pharmaceuticals (ALXN) United States $19.071B 8.87
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.120B 0.00
Incyte (INCY) United States $15.835B 33.98
BioMarin Pharmaceutical (BMRN) United States $14.869B 635.69
BioNTech SE (BNTX) Germany $12.444B 0.00
Genmab (GNMSF) Denmark $12.338B 39.68
Galapagos (GLPG) Belgium $12.125B 26.48
Alnylam Pharmaceuticals (ALNY) United States $12.122B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.935B 46.43
QIAGEN (QGEN) Netherlands $9.295B 28.34
Moderna (MRNA) United States $9.192B 0.00
Exact Sciences (EXAS) United States $9.010B 0.00
BeiGene (BGNE) Cayman Islands $8.226B 0.00
Sarepta Therapeutics (SRPT) United States $7.701B 0.00
Bio-Techne Corp (TECH) United States $7.146B 48.90
Guardant Health (GH) United States $6.713B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.139B 0.00
Ascendis Pharma (ASND) Denmark $5.402B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.400B 14.27
Exelixis (EXEL) United States $5.277B 16.94
ARGENX SE-ADR (ARGX) Netherlands $5.056B 0.00
Reata Pharmaceuticals (RETA) United States $4.948B 0.00
Amarin (AMRN) Ireland $4.894B 0.00
Repligen (RGEN) United States $4.761B 87.06
Acceleron Pharma (XLRN) United States $4.375B 0.00
China Biologic Products (CBPO) China $4.316B 25.62
MorphoSys AG (MOR) Germany $3.544B 0.00
Vir Biotechnology (VIR) United States $3.510B 0.00
Mirati Therapeutics (MRTX) United States $3.497B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.320B 0.00
Blueprint Medicines (BPMC) United States $3.308B 0.00
Adaptive Biotechnologies (ADPT) United States $3.307B 0.00
Global Blood Therapeutics (GBT) United States $3.163B 0.00
Zai Lab (ZLAB) China $3.056B 0.00
Emergent Biosolutions (EBS) United States $2.982B 20.70
NeoGenomics (NEO) United States $2.857B 123.86
Immunomedics (IMMU) United States $2.830B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.677B 45.35
Genmab (GMAB) Denmark $2.607B 10.23
Bluebird Bio (BLUE) United States $2.590B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.576B 0.00
Halozyme Therapeutics (HALO) United States $2.473B 0.00
MyoKardia (MYOK) United States $2.472B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.468B 0.00
Amicus Therapeutics (FOLD) United States $2.428B 0.00
Alkermes (ALKS) Ireland $2.271B 179.88
Intercept Pharmaceuticals (ICPT) United States $2.224B 0.00
RA PHARMCTL INC (RARX) United States $2.223B 0.00
Arena Pharmaceuticals (ARNA) United States $2.161B 5.63
Denali Therapeutics (DNLI) United States $2.034B 0.00
UniQure (QURE) Netherlands $1.989B 0.00
Alector (ALEC) United States $1.943B 0.00
Viela Bio (VIE) United States $1.928B 0.00
Eidos Therapeutics (EIDX) United States $1.862B 0.00
Principia Biopharma (PRNB) United States $1.838B 0.00
Epizyme (EPZM) United States $1.785B 0.00
Fate Therapeutics (FATE) United States $1.770B 0.00
Insmed (INSM) United States $1.661B 0.00
Arvinas (ARVN) United States $1.612B 0.00
Zymeworks (ZYME) Canada $1.491B 0.00
Akcea Therapeutics (AKCA) United States $1.460B 31.39
Dicerna Pharmaceuticals (DRNA) United States $1.350B 0.00
REGENXBIO (RGNX) United States $1.209B 0.00
Ligand Pharmaceuticals (LGND) United States $1.204B 37.40
Coherus BioSciences (CHRS) United States $1.186B 14.11
Editas Medicine (EDIT) United States $1.152B 0.00
Myriad Genetics (MYGN) United States $1.109B 19.58
Twist Bioscience (TWST) United States $1.072B 0.00
Zealand Pharma (ZEAL) Denmark $1.044B 0.00
Inovio Pharmaceuticals (INO) United States $1.042B 0.00
NextCure (NXTC) United States $1.029B 0.00
PHARMA MAR SA (PHMMF) Spain $0.985B 0.00
Adverum Biotechnologies (ADVM) United States $0.963B 0.00
NGM Biopharmaceuticals (NGM) United States $0.949B 0.00
Zealand Pharma (ZLDPF) Denmark $0.881B 0.00
Revance Therapeutics (RVNC) United States $0.867B 0.00
Intra-Cellular Therapies (ITCI) United States $0.861B 0.00
Sangamo Therapeutics (SGMO) United States $0.774B 0.00
Athenex (ATNX) United States $0.706B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.698B 0.00
Cytokineticsorporated (CYTK) United States $0.680B 0.00
Frequency Therapeutics (FREQ) United States $0.675B 0.00
Pharming Group (PHGUF) Netherlands $0.670B 0.00
Novavax (NVAX) United States $0.656B 0.00
Intellia Therapeutics (NTLA) United States $0.651B 0.00
Kadmon Holdings (KDMN) United States $0.649B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.625B 0.00
Cara Therapeutics (CARA) United States $0.623B 0.00
Codexis (CDXS) United States $0.618B 0.00
Retrophin (RTRX) United States $0.613B 0.00
Intrexon (PGEN) United States $0.582B 0.00
Arcus Biosciences (RCUS) United States $0.577B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.575B 0.00
GENFIT S.A (GNFT) France $0.550B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.537B 0.00
Bellus Health (BLU) Canada $0.524B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.502B 4.41
ANI Pharmaceuticals (ANIP) United States $0.492B 8.88
Compugen (CGEN) Israel $0.491B 0.00
MeiraGTx Holdings (MGTX) United States $0.485B 0.00
Castle Biosciences (CSTL) United States $0.483B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Heska (HSKA) United States $0.457B 0.00
Vericel (VCEL) United States $0.451B 66.93
Scholar Rock Holding (SRRK) United States $0.449B 0.00
AC Immune SA (ACIU) Switzerland $0.449B 10.38
Cel-Sci (CVM) United States $0.444B 0.00
DBV Technologies S.A (DBVT) France $0.437B 0.00
Mesoblast (MESO) Australia $0.436B 0.00
MiMedx (MDXG) United States $0.415B 0.00
Anika Therapeutics (ANIK) United States $0.413B 14.22
Morphic Holding (MORF) United States $0.411B 0.00
Verastem (VSTM) United States $0.406B 0.00
Prothena (PRTA) Ireland $0.404B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.400B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.400B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.398B 0.00
AnaptysBio (ANAB) United States $0.397B 0.00
Clovis Oncology (CLVS) United States $0.397B 0.00
Agenus (AGEN) United States $0.394B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.379B 0.00
Cue Biopharma (CUE) United States $0.378B 0.00
PDL BioPharma (PDLI) United States $0.373B 11.19
Adaptimmune Therapeutics (ADAP) United Kingdom $0.372B 0.00
Merus (MRUS) Netherlands $0.372B 0.00
Cellectis S.A (CLLS) France $0.370B 0.00
UROGEN PHARMA (URGN) United States $0.368B 0.00
Puma Biotechnology (PBYI) United States $0.357B 0.00
WAVE Life Sciences (WVE) Singapore $0.349B 0.00
NantKwest (NK) United States $0.342B 0.00
Sorrento Therapeutics (SRNE) United States $0.339B 0.00
BioDelivery Sciences (BDSI) United States $0.338B 39.00
Pfenex (PFNX) United States $0.332B 485.50
Athersys (ATHX) United States $0.315B 0.00
Precision BioSciences (DTIL) United States $0.310B 0.00
Cellular Biomedicine (CBMG) United States $0.310B 0.00
Dynavax Technologies (DVAX) United States $0.309B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.302B 0.00
CytomX Therapeutics (CTMX) United States $0.293B 0.00
Mersana Therapeutics (MRSN) United States $0.291B 0.00
Kala Pharmaceuticals (KALA) United States $0.283B 0.00
Avid Bioservices (CDMO) United States $0.280B 0.00
Albireo Pharma (ALBO) United States $0.278B 0.00
ADMA Biologics Inc (ADMA) United States $0.269B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.257B 0.00
Seres Therapeutics (MCRB) United States $0.249B 0.00
Kamada (KMDA) Israel $0.247B 10.26
Syros Pharmaceuticals (SYRS) United States $0.246B 0.00
Sutro Biopharma (STRO) United States $0.245B 0.00
MannKind (MNKD) United States $0.234B 0.00
Alcobra (ARCT) United States $0.231B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.226B 0.00
Gritstone Oncology (GRTS) United States $0.226B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.225B 0.00
Geron (GERN) United States $0.224B 0.00
Aduro Biotech (ADRO) United States $0.221B 0.00
Stemline Therapeutics (STML) United States $0.214B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.209B 1.88
OSMOTICA PHARM (OSMT) United States $0.196B 0.00
HOOKIPA Pharma (HOOK) United States $0.192B 0.00
XOMA (XOMA) United States $0.190B 0.00
Selecta Biosciences (SELB) United States $0.185B 0.00
VBI Vaccines (VBIV) United States $0.182B 0.00
IVERIC Bio (ISEE) United States $0.180B 0.00
ChromaDex (CDXC) United States $0.179B 0.00
Kindred Biosciences (KIN) United States $0.177B 0.00
Abeona Therapeutics (ABEO) United States $0.176B 0.00
Protagonist Therapeutics (PTGX) United States $0.173B 0.00
Spero Therapeutics (SPRO) United States $0.164B 0.00
Biofrontera AG (BFRA) Germany $0.159B 0.00
Arbutus Biopharma (ABUS) Canada $0.156B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.151B 0.00
Cerecor (CERC) United States $0.150B 0.00
Prometic Life Sciences (LMNL) Canada $0.150B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.150B 0.00
Starpharma Holdings (SPHRY) Australia $0.149B 0.00
VolitionRX (VNRX) United States $0.149B 0.00
POXEL SA FRANCE (PXXLF) France $0.145B 0.00
Liquidia Technologies (LQDA) United States $0.138B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.135B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.135B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.134B 5.27
Fortress Biotech (FBIO) United States $0.134B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Windtree Therapeutics (WINT) United States $0.134B 0.00
VTv Therapeutics (VTVT) United States $0.132B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.124B 0.00
Theratechnologies (THTX) Canada $0.124B 0.00
Dyadic (DYAI) United States $0.122B 0.00
Antibe Therapeutics (ATBPF) Canada $0.120B 0.00
Affimed (AFMD) Germany $0.120B 0.00
Exicure (XCUR) United States $0.119B 0.00
Enzo Biochem (ENZ) United States $0.118B 0.00
Strongbridge Biopharma (SBBP) United States $0.110B 0.00
Palatin Technologies (PTN) United States $0.108B 2.94
Celyad SA (CYAD) Belgium $0.106B 0.00
AIT Therapeutics (XAIR) United States $0.104B 0.00
CorMedix Inc (CRMD) United States $0.100B 0.00
Cidara Therapeutics (CDTX) United States $0.100B 0.00
Northwest Biotherapeutics (NWBO) United States $0.099B 0.00
OvaScience (MLND) United States $0.099B 0.00
Checkpoint Therapeutics (CKPT) United States $0.097B 0.00
Aptinyx (APTX) United States $0.097B 0.00
Five Prime Therapeutics (FPRX) United States $0.093B 0.00
PHASEBIO PHARMA (PHAS) United States $0.092B 0.00
IBio (IBIO) United States $0.091B 0.00
TELA Bio (TELA) United States $0.091B 0.00
Cyclerion Therapeutics (CYCN) United States $0.090B 0.00
Clearside Biomedical (CLSD) United States $0.083B 0.00
ARAVIVE, INC (ARAV) United States $0.078B 0.00
Happiness Biotech Group (HAPP) China $0.077B 0.00
Menlo Therapeutics (MNLO) United States $0.077B 0.00
Vaccinex (VCNX) United States $0.072B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.072B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.069B 0.00
SESEN BIO, INC (SESN) United States $0.068B 0.00
Aytu Bioscience (AYTU) United States $0.067B 0.00
Adocia (ADOCY) France $0.066B 0.00
Applied Genetic Technologies (AGTC) United States $0.066B 0.00
Proteostasis Therapeutics (PTI) United States $0.065B 0.00
Synlogic (SYBX) United States $0.065B 0.00
Orgenesis (ORGS) United States $0.062B 3.66
Eton Pharmaceuticals (ETON) United States $0.060B 0.00
Trevena (TRVN) United States $0.059B 0.00
AquaBounty Technologies (AQB) United States $0.059B 0.00
Pluristem Therapeutics (PSTI) Israel $0.058B 0.00
Catalyst Biosciences (CBIO) United States $0.057B 0.00
Emmaus Life Sciences (EMMA) United States $0.056B 0.00
Acorda Therapeutics (ACOR) United States $0.053B 0.00
Vascular Biogenics (VBLT) Israel $0.052B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.049B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.049B 0.00
Idera Pharmaceuticals (IDRA) United States $0.042B 0.00
Soligenix (SNGX) United States $0.038B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.037B 0.00
Organovo Holdings (ONVO) United States $0.037B 0.00
AmpliPhi Biosciences (ARMP) United States $0.036B 0.00
Advaxis (ADXS) United States $0.036B 0.00
Lumos Pharma (LUMO) United States $0.035B 0.00
Protalix BioTherapeutics (PLX) Israel $0.035B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.034B 0.00
TOCAGEN INC (TOCA) United States $0.034B 0.00
DiaMedica Therapeutics (DMAC) United States $0.034B 0.00
CollPlant Holdings (CLGN) Israel $0.034B 0.00
Prima BioMed (IMMP) Australia $0.030B 0.00
Signal Genetics (MGEN) United States $0.030B 0.00
Celldex Therapeutics (CLDX) United States $0.029B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.029B 0.00
Evogene (EVGN) Israel $0.028B 0.00
Curis (CRIS) United States $0.027B 0.00
Entera Bio (ENTX) Israel $0.027B 0.00
VistaGen Therapeutics (VTGN) United States $0.024B 0.00
Alimera Sciences (ALIM) United States $0.023B 0.00
Novogen (KZIA) Australia $0.022B 0.00
Pulmatrix (PULM) United States $0.021B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.021B 0.00
Celsion (CLSN) United States $0.021B 0.00
Stellar Biotechnologies (EDSA) Canada $0.019B 0.00
Apricus Biosciences (SEEL) United States $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.019B 0.00
BioCardia (BCDA) United States $0.019B 0.00
Oncobiologics (OTLK) United States $0.018B 0.00
Titan Pharmaceuticals (TTNP) United States $0.017B 0.00
Bionano Genomics (BNGO) United States $0.017B 0.00
Unum Therapeutics (UMRX) United States $0.015B 0.00
Aptevo Therapeutics (APVO) United States $0.012B 0.00
AEterna Zentaris (AEZS) United States $0.012B 0.00
ATyr Pharma (LIFE) United States $0.012B 0.00
TrovaGene (TROV) United States $0.010B 0.00
VIVUS (VVUS) United States $0.010B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
MYOS RENS Technology (MYOS) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
TRACON Pharmaceuticals (TCON) United States $0.009B 0.00
Cesca Therapeutics (THMO) United States $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.007B 0.00
IMMURON (IMRN) Australia $0.007B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
Neuralstem (SNCA) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Spherix (AIKI) United States $0.003B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00